Molecular Diagnosis of TB in the HIV Positive Population

Molecular Diagnosis of TB in the HIV Positive Population

Background: <a title="Learn more about Tuberculosis" href="https://www.sciencedirect.com/topics/medicine-and-dentistry/tuberculosis">Tuberculosis</a> (TB) remains a major contributor to <a title="Learn more about Morbidity" href="https://www.scienced...

Full description

Bibliographic Details
Main Authors:	Amy Y. Vittor, Joseph M. Garland, Robert H. Gilman
Format:	Article
Language:	English
Published:	Ubiquity Press 2015-05-01
Series:	Annals of Global Health
Subjects:	drug susceptibility testing HIV molecular diagnostics RNA transcription signatures tuberculosis Xpert MTB/RIF
Online Access:	https://annalsofglobalhealth.org/articles/2087

Similar Items

Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
by: Mary Mansfield, et al.
Published: (2022-06-01)

Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum
by: Xia Yu, et al.
Published: (2023-08-01)

The Role of GeneXpert<sup>®</sup> for Tuberculosis Diagnostics in Brazil: An Examination from a Historical and Epidemiological Perspective
by: Tirça Naiara da Silva Iúdice, et al.
Published: (2023-10-01)

High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana
by: Justice K Boakye-Appiah, et al.
Published: (2016-01-01)

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01)

The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda
by: A. Andama, et al.
Published: (2021-01-01)

Screening of Human Immunodeficiency Virus (HIV) among Newly Diagnosed Tuberculosis Patients in Eastern Sudan
by: GADA MUSTAFA AHMED MUSTAFA, et al.
Published: (2021-05-01)

More Than a Decade of GeneXpert<sup>®</sup> <i>Mycobacterium tuberculosis</i>/Rifampicin (Ultra) Testing in South Africa: Laboratory Insights from Twenty-Three Million Tests
by: Manuel Pedro da Silva, et al.
Published: (2023-10-01)

Rolling out Xpert MTB/RIF® for tuberculosis detection in HIV-positive populations: An opportunity for systems strengthening
by: Ishani Pathmanathan, et al.
Published: (2017-03-01)

Diagnostic accuracy of GeneXpert MTB/RIF in musculoskeletal tuberculosis: High sensitivity in tissue samples of HIV-infected and HIV-uninfected patients
by: M Held, et al.
Published: (2017-10-01)

Breast tuberculosis: A forgotten diagnosis
by: S. Oucharqui, et al.
Published: (2021-01-01)

Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV
by: Edith E. Machowski, et al.
Published: (2021-05-01)

Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers
by: Nicole L. Rendell, et al.
Published: (2017-07-01)

Study of diagnostic utility of Xpert MTB/Rif test on pleural fluid in the evaluation of patients presenting with Pleural Tuberculosis in Nepal
by: Deebya Raj Mishra, et al.
Published: (2022-01-01)

Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh
by: Samanta Biswas, et al.
Published: (2022-01-01)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
by: Raksha Rimal, et al.
Published: (2022-04-01)

Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India
by: Rakesh Yadav, et al.
Published: (2020-01-01)

Use of the urine Determine LAM test in the context of tuberculosis diagnosis among inpatients with HIV in Ghana: a mixed methods study
by: Johanna Åhsberg, et al.
Published: (2024-01-01)

Diagnostic value of tNGS vs Xpert MTB/RIF in childhood TB
by: Huiwen Zheng, et al.
Published: (2024-01-01)

Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort study
by: Xia Yu, et al.
Published: (2022-09-01)

Diagnostic accuracy of xpert test in tuberculosis detection: A systematic review and meta-analysis
by: Ravdeep Kaur, et al.
Published: (2016-01-01)

A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
by: Xichao Ou, et al.
Published: (2015-02-01)

Evaluación del rendimiento del ensayo GeneXpert MTB/RIF en muestras con sospecha de tuberculosis extrapulmonar recibidas en el C.H.DR.A.A.M. de enero 2020-diciembre 2021
by: Oneira T. Riquelme, et al.
Published: (2023-06-01)

Evaluación del rendimiento del ensayo GeneXpert MTB/RIF en muestras con sospecha de tuberculosis extrapulmonar recibidas en el C.H.DR.A.A.M. de enero 2020-diciembre 2021
by: Oneira T. Riquelme, et al.
Published: (2023-06-01)

Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial
by: Tefera Agizew, et al.
Published: (2019-12-01)

Paradoxical results of two automated real-time PCR assays in the diagnosis of pleural tuberculosis
by: Soraya E. Morales-López, et al.
Published: (2017-01-01)

The in-hospital tuberculosis diagnostic cascade and early clinical outcomes among people living with HIV before and during the COVID-19 pandemic - a prospective multisite cohort study from Ghana
by: Johanna Åhsberg, et al.
Published: (2023-03-01)

Cost-effectiveness analysis of Xpert in detecting Mycobacterium tuberculosis: A systematic review
by: Xiaohui Hao, et al.
Published: (2020-06-01)

The New Xpert MTB/RIF Ultra: Improving Detection of <italic toggle="yes">Mycobacterium tuberculosis</italic> and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing
by: Soumitesh Chakravorty, et al.
Published: (2017-09-01)

Prevalence of tuberculosis among symptomatic individuals and the risk areas in Ondo State, Nigeria
by: Olatunji Odeyemi, et al.
Published: (2023-12-01)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
by: Yeliz Tanriverdi Cayci, et al.

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
by: Nhu Nguyen Thi Quynh, et al.
Published: (2013-01-01)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
by: Julia V. Ershova, et al.
Published: (2020-07-01)

Xpert MTB/RIF(r) como herramienta diagnóstica en una cohorte de niños menores de 15 años con sospecha clínica de tuberculosis pulmonar en un hospital de alta complejidad de Medellín
by: Santiago León Atehortúa Muñoz, et al.

Performance of Xpert MTB/RIF Ultra for the Diagnosis of Pulmonary Tuberculosis Using Bronchoalveolar Lavage Samples in People Living with HIV/AIDS (PLWHA) in China: A Prospective Study
by: Zhang P, et al.
Published: (2021-09-01)

The role of Xpert MTB/RIF using bronchoalveolar lavage fluid in active screening: insights from a tuberculosis outbreak in a junior school in eastern China
by: Qian Wu, et al.
Published: (2023-12-01)

Use of string test and stool specimens to diagnose pulmonary tuberculosis
by: Andrew R. DiNardo, et al.
Published: (2015-12-01)

Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
by: F. Bahraminia, et al.
Published: (2021-07-01)

Comparative study between microscopic observation drug susceptibility and MTB/RIF Gene Xpert in the diagnosis of pulmonary tuberculosis in a specialized Egyptian hospital
by: Sahar M Mourad, et al.
Published: (2021-01-01)

Xpert MTB/RIF assay for diagnosis of extrapulmonary tuberculosis in children: a systematic review and meta-analysis
by: Young Seok Seo, et al.
Published: (2020-01-01)